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Background: In general, previous studies have shown an association between prior 
exacerbations and mortality in COPD, but this association has not been demonstrated in the 
subpopulation of patients in need of assisted ventilation. We examined whether previous 
hospitalizations were independently associated with mortality among patients with COPD 
ventilated for the first time.
Patients and methods: In the Danish National Patient Registry, we established a cohort of 
patients with COPD ventilated for the first time from 2003 to 2011 and previously medicated 
for obstructive airway diseases. We assessed the number of hospitalizations for COPD in the 
preceding year, age, sex, comorbidity, mode of ventilation, survival to discharge, and days to 
death beyond discharge.
Results: The cohort consisted of 6,656 patients of whom 66% had not been hospitalized for 
COPD in the previous year, 18% once, 8% twice, and 9% thrice or more. In-hospital mortal-
ity was 45%, and of the patients alive at discharge, 11% died within a month and 39% within 
a year. In multivariate models, adjusted for age, sex, mode of ventilation, and comorbidity, odds 
ratios for in-hospital death were 1.26 (95% confidence interval [CI]: 1.11–1.44), 1.43 (95% 
CI: 1.19–1.72), and 1.56 (95% CI: 1.30–1.87) with one, two, and three or more hospitalizations, 
respectively. Hazard ratios for death after discharge from hospital were 1.32 (95% CI: 1.19–1.46), 
1.76 (95% CI: 1.52–2.02), and 2.07 (95% CI: 1.80–2.38) with one, two, and three or more 
hospitalizations, respectively.
Conclusion: Preceding hospitalizations for COPD are associated with in-hospital mortality 
and after discharge in the subpopulation of patients with COPD with acute exacerbation treated 
with assisted ventilation for the first time.
Keywords: pulmonary disease, chronic obstructive, respiration, artificial, patient readmission, 
hospital mortality, critical care
Introduction
COPD is a persistent, progressive airflow limitation associated with a chronic airway 
inflammation and is among the leading causes of mortality and morbidity worldwide, 
in fact predicted to be the third leading cause of death by 2020.1
An acute exacerbation of COPD (AECOPD), defined as worsening of symptoms 
beyond normal day-to-day variation, is associated with increased mortality.1–3 In gen-
eral, exacerbations are more frequent in severe COPD,4,5 but recent studies show that 
the number of exacerbations varies extensively among patients with COPD with similar 
lung function in stable phases. Nevertheless, exacerbations are the best predictor of 
their own recurrence.3,4,6 It has been suggested that an inherent “frequent-exacerbation 
phenotype” with a distinct pathophysiology might explain at least parts of the extensive 
clinical variability.4,7 Previous accumulated exacerbations have been shown to predict 
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not only new exacerbations but also mortality. This prediction 
is independent of stable phase lung function impairment, and 
mortality increases by each subsequent exacerbation.5,8–11 It is 
not known whether the association between previous exac-
erbations and mortality is independent of the degree of acute 
illness. Patients subjected to assisted ventilation constitute 
a group whose acute illness is severe, and the association 
between previous exacerbations and mortality in this group 
has not been elucidated.
The overall short-term mortality among patients with 
acute exacerbations ranges from 2.1% to 20.4%,9,12,13 but 
patients with severe acute COPD admitted to intensive care 
unit (ICU) are particularly at risk with a 6-month mortality 
ranging from 25% to 40%.12,14,15 In-hospital mortality rates for 
patients being ventilated are 5%–25% but higher in relation 
to invasive mechanical ventilation (IMV) than to noninvasive 
mechanical ventilation (NIV).16–20 Predictors of mortality in 
hospitalized patients with COPD12,21,22 are age, comorbidities, 
and end-stage COPD with concomitant organ dysfunctions. 
Lung function impairment in stable phase is in itself a poor 
predictor of short-term mortality following exacerbations8,23 
but is associated with long-term mortality.24 On the other 
hand, acidosis, which mirrors acute derangement, predicts 
short-term but not long-term mortality.12 In patients admitted 
to ICU, acute derangement is of major importance regard-
ing both short-term25,26 and intermediate-term survival,15 but 
long-term survival studies have been conflicting with regard 
to independent risk predictors.14,27–31
The aim of this study was to investigate whether the 
frequency of previous hospitalizations for AECOPD can 
predict in-hospital mortality and mortality after discharge 
in an inception cohort of patients with COPD treated with 
assisted ventilation for the first time. We hypothesized that 
frequent COPD hospitalizations were associated with excess 
mortality following assisted ventilation.
Patients and methods
All hospitalizations from 2002 to 2011 were identified in the 
Danish National Patient Registry. Successive hospitalizations 
were merged if the discharge date of the first and the admission 
date of the second were identical. AECOPD hospitalizations 
were defined as hospitalizations with either a primary diagno-
sis of COPD (International Classification of Diseases, tenth 
edition [ICD-10]: DJ44) or a complex of either acute respira-
tory failure (ICD-10: DJ96) or pneumonia (ICD-10: DJ13–18) 
as the primary diagnosis and COPD as a secondary diagnosis 
as described by Thomsen et al.32 In general, hospitalizations 
related to diseases of the respiratory system (respiratory 
hospitalizations) were identified by a primary diagnosis 
within the entire ICD-10 DJ-spectrum. No attempts were 
made to distinguish between admissions for exacerbations 
with and without pneumonia. Patients ,30 years of age were 
excluded to minimize inclusion of misclassified asthma. First 
time ventilation was defined as the first AECOPD hospital-
ization where assisted ventilation was performed, but first 
time ventilations in 2002 were discarded as no specific pro-
cedure code for NIV was accessible till 2003. In the National 
Register of Medicinal Product Statistics, all prescriptions in 
the year preceding first time hospitalizations were identified. 
By ATC code “R03”, drugs for obstructive airway diseases 
were identified. First time ventilation was classified as the 
index hospitalization if a prescription was redeemed within 
1 year before. Any patient with an index hospitalization was 
included in the cohort (Figure 1). Mode of ventilation at the 
Figure 1 The inclusion of patients.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic
 O
bs
tr
uc
tiv
e 
P
ul
m
on
ar
y 
D
is
ea
se
 d
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//w
w
w
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
22
5.
19
8.
24
5 
on
 2
2-
D
ec
-2
01
7
F
or
 p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD 2016:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
937
Ventilation in COPD – previous admissions and mortality
index hospitalization was characterized as either “IMV” 
(BGDA0) or “NIV” (BGDA1). The categories were mutually 
exclusive and hierarchically assigned so that IMV overruled 
NIV, if both were registered.
The number of AECOPD and respiratory system-related 
hospitalizations in the year preceding the index hospitalization 
was counted. Charlson comorbidity score based on diagnoses 
made during hospitalizations and outpatient visits 10 years 
prior to the discharge from the index hospitalization were 
assigned to individual diseases ad modum Radovanovic et al33 
and grouped in three with 1, 2, or 3+ points, respectively, as per 
definition all patients received one point for having COPD.
Information on day of death was obtained from the 
Danish Civil Registration System. Each patient was followed 
until the time of death or censured by December 31, 2013. 
Informed consent was not required according to Danish 
legislation.
General characteristics between groups were compared 
by chi-square test (character variables) and Kruskal–Wallis 
test (continuous variable). For analysis of in-hospital mortal-
ity, logistic regression was used, and for analysis of mortality 
beyond discharge, Cox proportional hazards models were 
used. In both models, continuous variables were tested for 
linearity, and in the Cox model, dependency of the estimates 
on time was evaluated by the Schoenfeld residuals. Interac-
tions a priori were considered relevant, that is, interactions 
between previous hospitalizations, and age, sex, and mode 
of ventilation, respectively, were tested for by comparisons 
of likelihood. P-values ,0.05 were considered significant. 
Statistical analyses were performed in SAS 9.4© (SAS 
Institute Inc., Cary, NC, USA) and R© Version 3.1.1.
Results
The population consisted of 6,656 patients (Table 1). Of 
these, 65% had not been hospitalized for AECOPD in the 
preceding year, 18% had been hospitalized once, 8% twice, 
and 9% thrice or more. The proportion excluded was 50% in 
the group of patients not hospitalized in the previous year and 
44%, 41%, and 45% in the group hospitalized once, twice, 
and thrice, respectively. Mortality rates are shown in Tables 2 
and 3. The annual number of first time ventilations for COPD 
exacerbation increased from 355 in 2003 to 1,236 in 2011.
Increasing age, high Charlson comorbidity score, and 
IMV were the risk factors for in-hospital mortality. The 
risk decreased during the study period. For all patients, in-
hospital mortality was associated with the number of previ-
ous AECOPD hospitalizations. The odds ratios, compared 
to no previous hospitalizations, were 1.26 (95% confidence 
interval [CI]: 1.11–1.44) with one hospitalization, 1.43 (95% 
CI: 1.19–1.72) with two hospitalizations, and 1.56 (95% CI: 
1.30–1.87) with three or more hospitalizations (Figure 2). 
The risk associated with three or more hospitalizations 
was significantly higher than the risk associated with one 
hospitalization (P=0.04).
Table 1 Characteristics of included patients at baseline by number of COPD hospitalizations in the previous year
Characteristics Number of admissions in the previous year
0 1 2 3+ Total
n=4,333 n=1,213 n=538 n=572 n=6,656
sex
Male 2,481 (57.3%) 684 (56.4%) 305 (56.7%) 320 (55.9%) 3,790 (56.9%)
age, year
Median (IQr) 74.1 (66.4–79.8) 74.8 (67.5–80.6) 73.9 (67.1–80.0) 72.9 (65.1–77.9) 74.1 (66.5–79.8)
Charlson comorbidity score
1 1,691 (39.0%) 429 (35.4%) 183 (34.0%) 216 (37.8%) 2,519 (37.8%)
2 1,051 (24.3%) 278 (22.9%) 131 (24.3%) 150 (26.2%) 1,610 (24.2%)
3+ 1,591 (36.7%) 506 (41.7%) 224 (41.6%) 206 (36.0%) 2,527 (38.0%)
Time period
2003–2005 856 (19.8%) 247 (20.4%) 120 (22.3%) 133 (23.3%) 1,356 (20.4%)
2006–2008 1,410 (32.5%) 412 (34.0%) 181 (33.6%) 191 (33.4%) 2,194 (33.0%)
2009–2011 2,067 (47.7%) 554 (45.7%) 237 (44.1%) 248 (43.4%) 3,106 (46.7%)
Mode of ventilation
nIV 2,316 (53.5%) 726 (59.9%) 346 (64.3%) 389 (68.0%) 3,777 (56.7%)
length of stay
1–2 days 406 (9.4%) 126 (10.4%) 81 (15.1%) 64 (11.2%) 677 (10.2%)
3–7 days 1,023 (23.6%) 333 (27.5%) 157 (29.2%) 178 (31.1%) 1,691 (25.4%)
7+ days 2,904 (67.0%) 754 (62.2%) 300 (55.8%) 330 (57.7%) 4,288 (64.4%)
Abbreviations: IQr, interquartile rage; nIV, noninvasive mechanical ventilation.
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Mortality after discharge from hospital was associated 
with female sex, increasing age, Charlson comorbidity score, 
and NIV. The risk decreased during the study period. For all 
patients, the number of previous AECOPD hospitalizations 
was associated with an increased mortality after discharge 
compared to no previous hospitalizations with a hazard ratio 
of 1.32 (95% CI: 1.19–1.46) with one hospitalization, 1.76 
(95% CI: 1.52–2.02) with two hospitalizations, and 2.07 (95% 
CI: 1.80–2.38) with three or more hospitalizations (Figure 3). 
The risks associated with two and with three or more hospital-
izations were significantly higher than the risk associated with 
one hospitalization (P,0.001 and P,0.001, respectively).
The associations with both in-hospital and after-discharge 
mortality showed the same trends, though weaker, 
when, instead of AECOPD hospitalizations, respiratory 
hospitalizations were included in the model (Figure 4).
Discussion
In this study of patients ventilated for COPD for the first time, 
an increasing number of hospitalizations in the preceding year 
were associated with increased overall mortality. We found 
significant odds ratios for in-hospital death ranging from 1.3 
to 1.6 with increasing number of hospitalizations with COPD 
exacerbations within the previous year. To our knowledge, 
this association has not been studied in this subgroup of 
patients. A number of studies have examined the association 
between previous exacerbations and mortality in other COPD 
subpopulations, and in some of these, the association was far 
stronger than what we found.
Hospital contact for exacerbation within the previous year 
was associated with adverse events within a month, odds ratio 
3.9 (95% CI: 1.6–9.9).22 Likewise, having had at least two 
hospitalizations within the previous 2 years was associated 
with 30 days mortality, odds ratio 3.6 (95% CI: 2.5–5.2).34 
Among ICU admitted patients with COPD, two or more 
exacerbations within the previous year were associated with in-
hospital mortality, odds ratio 9.1 (95% CI: 1.02–81.1).11 Apart 
from different outcome measurements, the discrepancy in the 
magnitude of the correlations might be explained by different 
case mixes. Patients with end-stage COPD, which presumably 
have more frequent exacerbations, may to some extent have 
been excluded from our cohort due to advancement orders that 
ruled out ventilation. Whether the stage of stable phase COPD 
modifies the correlation between the number of hospitalizations 
and short-term mortality needs to be further evaluated.
Among patients with COPD in Denmark, Schmidt 
et al35 found significant association between neither previ-
ous overall exacerbations nor previous hospitalized exac-
erbations and 30-day mortality after hospitalization for 
exacerbation upon adjustment for age, sex, comorbidities, 
and previous medication. Patients in this cohort, in contrast 
to those included in ours, were dissimilar with regard to 
the acute severity of the exacerbation due to a case mix of 
ventilated and nonventilated patients. Moreover, first time 
and repeated hospitalizations were evaluated together, and 
redeemed prescriptions for obstructive airway diseases 
medication were not a criterion for inclusion. Another study 
of 3-month mortality showed that previous hospitalizations 
were not a significant predictor of mortality upon inclusion 
of markers of acute derangement and performance status.36 
It is possible, though, that the decision of admitting a patient 
with any given degree of acute illness depends on perfor-
mance status, thus masking an association between previous 
hospitalizations and mortality.
Table 2 In-hospital mortality by number of COPD hospitalizations in the previous year
Number of admissions in the previous year
0 1 2 3+ Total
n=4,333 n=1,213 n=538 n=572 n=6,656
Mortality, n (%)
Death before discharge 1,832 (42%) 585 (48%) 270 (50%) 286 (50%) 2,973 (45%)
Table 3 Mortality after discharge by number of COPD hospitalizations in the previous year
Number of admissions in the previous year
0 1 2 3+ Total
n=2,501 n=628 n=268 n=286 n=3,683
Mortality
Death within 30 days 236 (9%) 99 (16%) 41 (15%) 44 (15%) 420 (11%)
Death within 1 year 827 (33%) 296 (47%) 158 (59%) 169 (59%) 1,450 (39%)
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In our study population, mortality after discharge 
was associated with previous exacerbations with hazard 
ratios in the range of 1.3–2.0 for one and three or more 
hospitalizations, respectively. The aforementioned Danish 
study35 also found a significant association between long-
term mortality and the number of COPD exacerbations. The 
strength of the association is comparable to what we found 
and to what was found in a Spanish study.37
A large American study38 found a lower hazard ratio after 
discharge of 1.14 by each previous hospitalization in a 1-year 
period. However, the inclusion criteria as well as the case 
mix were profoundly different from ours, and in addition, 
immortal time bias might partly account for the estimate 
being lower than ours. No independent association was found 
in another study by Almagro et al,39 but stable phase lung 
function impairment correlated strongly with prognosis and 
might have masked an association.
Our study confirmed the importance of age and 
comorbidity, while sex was only associated with mortality 
after discharge. Mortality risk decreased with time. IMV as 
Figure 2 logistic regression model of in-hospital mortality.
Note: *Significant at P,0.05.
Abbreviations: nIV, noninvasive mechanical ventilation; IMV, invasive mechanical ventilation.
Figure 3 Cox proportional hazards model of mortality after discharge.
Note: *indicates significant at P,0.05.
Abbreviations: nIV, noninvasive mechanical ventilation; IMV, invasive mechanical ventilation.
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a mode of ventilation predicted death before discharge 
independently, whereas NIV predicted time to death after 
discharge. IMV is mainly initiated in patients with severe 
acute derangement, which probably accounts for the associ-
ated higher in-hospital mortality compared to NIV. That this 
relation is reversed after discharge can have several explana-
tions, among those that patients discharged alive after IMV 
treatment had undergone harder selection.
In comparison with other studies, our estimate of in-
hospital mortality of ventilated patients is high,16,31,40 but 
this might partly be explained by inclusion in our study of 
patients with COPD with pneumonia, which confers a large 
additional risk.41
The association between treatment year and risk might 
be explained by increasingly aggressive strategies for stable 
phase medication and for ventilation during exacerbations. 
Assuming that both medication and ventilation have mainly 
gained a stronger foothold among less afflicted patients with 
COPD, gradual rarefication of mortality by the inherently 
favorable prognosis of this group can explain the improve-
ment of prognosis.42
The strengths of our study are the large number of patients 
and the high reliability of the Danish medical registers, which 
is well established for a number of diagnoses,43 among those 
the COPD diagnosis applied here (a positive predictive 
value of 92%),32 procedures,44 and vital status.45 In addition, 
Figure 4 respiratory hospitalizations.
Notes: (A) logistic regression model of in-hospital mortality, (B) Cox proportional hazards model of mortality after discharge. *indicates significant at P,0.05.
Abbreviations: nIV, noninvasive mechanical ventilation; IMV, invasive mechanical ventilation.
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the inherent ability to track unique patient courses virtually 
eliminates all but emigration as loss to follow-up.
Our study has noteworthy limitations. Misclassification 
is in our data set especially problematic with regard to the 
calculated comorbidity, where completeness of registration 
will be highest among frequently hospitalized patients. 
However, the use of Charlson comorbidity score has been 
shown to yield acceptable precision when calculated from 
registers,46 although the sensitivity of secondary diagnoses 
in the National Patient Registry is known to be low.47 We 
speculated whether the number of previous hospitalizations 
decided by our method could underestimate the number 
of hospitalizations as the propensity to register a COPD 
diagnosis in connection with a hospitalization might depend 
on the COPD stage. Such misclassification might even be 
differential as only previously admitted patients could be 
misclassified. To test this, we substituted respiratory hospital-
izations for COPD hospitalizations, which did not materially 
change the results.
We chose to include only patients with COPD who had 
redeemed prescriptions for obstructive airway diseases 
medication within the year preceding ventilation. This 
excluded 49% of all patients whose hospitalizations would 
have qualified as index hospitalizations. This might reflect 
not only low compliance but also the inclusion of patients 
with breathing difficulties whose history was suggestive of 
COPD but who did not have symptoms on a daily basis. It is 
surprising and concerning that the proportion of patients who 
had not redeemed medication was almost equal in patients 
who had no previous admissions and in patients who had 
been repeatedly hospitalized. Exclusion in this case is a 
trade-off between generalizability and validity. It is gener-
ally assumed that previous medication acts as a proxy for 
previously recognized COPD, and thereby to some extent 
as a marker of stable phase disease severity. Previously, it 
has been shown that majority of the COPD population are 
unaware of their disease48 and that a considerable proportion 
of even patients with advanced disease (25%) do not receive 
appropriate treatment.49 Even so, in general, the unrecog-
nized cases have less advanced disease, are hospitalized 
less frequently after the hospitalization where the diagnosis 
was established,50 and have less severe symptoms prior to 
exacerbations.50
Other limitations to our study are the lack of information 
on lung function prior to the hospitalization, the degree of 
acute physiological derangement, and the extent of limita-
tions in care. Differences in underlying acute and chronic 
lung function impairment might confound the association 
between previous hospitalizations and mortality. However, 
we do consider this to be partly ameliorated by the inclusion 
of only such patients as had been offered ventilation upon 
clinical decision. Wildman et al51 have shown that clini-
cians are overly pessimistic when predicting the survival of 
patients with COPD on hospitalization to specialized respira-
tory units or ICUs, so it must be assumed that the instigation 
of assisted ventilation, at least invasive ventilation, among 
patients with very severe lung function impairment is limited. 
As for variation in severity of present respiratory failure, 
any subject hospitalized to our selected study population 
had an overall acute derangement warranting assisted ven-
tilation, and it must be assumed that the gas exchange was 
considerably impaired in most of our subjects. In pace with 
the dissemination of NIV as an accessible treatment option, 
NIV has to some extent become the interventional limit for a 
group of frail, elderly patients with often advanced COPD.19 
We did not have access to information on do-not-intubate-
orders, but a previous Danish study found such orders in 
10% of NIV patients.52 Presumably, a subpopulation of 
patients with short expected life span diluted the survival 
in the NIV group.
Conclusion
In conclusion, among the patients with COPD with acute 
exacerbation treated with assisted ventilation for the first 
time, the number of hospitalizations for COPD in the preced-
ing year is associated with increased mortality in-hospital as 
well as after discharge. Our study did not aim at identifying 
patients in whom assisted ventilation is futile. Nonetheless, 
it emphasizes the importance of the clinical trajectory for the 
outcome following ventilation in a group of patients whose 
mortality is very high.
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